Found: 11
Select item for more details and to access through your institution.
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 4050, doi. 10.3390/jcm9124050
- By:
- Publication type:
- Article
Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs.
- Published in:
- Cancer Science, 2006, v. 97, n. 6, p. 510, doi. 10.1111/j.1349-7006.2006.00204.x
- By:
- Publication type:
- Article
Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2023, v. 68, n. 2, p. 102, doi. 10.1159/000528867
- By:
- Publication type:
- Article
Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer Xenografts.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 1, p. 46, doi. 10.1159/000486029
- By:
- Publication type:
- Article
Association of right-sided tumors with high thymidine phosphorylase gene expression levels and the response to oral uracil and tegafur/leucovorin chemotherapy among patients with colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 2, p. 285, doi. 10.1007/s00280-012-1909-8
- By:
- Publication type:
- Article
Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 515, doi. 10.1007/s00280-006-0293-7
- By:
- Publication type:
- Article
Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors.
- Published in:
- Oncology, 2010, v. 79, n. 1/2, p. 55, doi. 10.1159/000319540
- By:
- Publication type:
- Article
Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728.
- Published in:
- Cancer Science, 2020, v. 111, n. 6, p. 2123, doi. 10.1111/cas.14407
- By:
- Publication type:
- Article
Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
- Published in:
- Oncology Reports, 2014, v. 32, n. 6, p. 2319, doi. 10.3892/or.2014.3487
- By:
- Publication type:
- Article
Depolymerized holothurian glycosaminoglycan (DHG), a novel alternative anticoagulant for hemodialysis, is safe and effective in a dog renal failure model.
- Published in:
- Kidney International, 2003, v. 63, n. 4, p. 1548, doi. 10.1046/j.1523-1755.2003.00879.x
- By:
- Publication type:
- Article
Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin.
- Published in:
- Journal of Biochemistry, 1996, v. 119, n. 1, p. 63, doi. 10.1093/oxfordjournals.jbchem.a021217
- By:
- Publication type:
- Article